Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4126 AL 4140

Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification

Yelleswarapu NK, Sidiropoulos C.

Int J Mol Sci. 2026 Mar 11;27(6):2560. doi: 10.3390/ijms27062560.

AI-Enabled Flexible Sensing Ecosystems for Parkinson's Disease: Advancing Digital Biomarkers and Closed-Loop Interventions

Jin J, Jiang Y, Zhou Y, Zhu W, Hua J, Cheng W, Shi Y, Pan L.

Sensors (Basel). 2026 Mar 26;26(7):2071. doi: 10.3390/s26072071.

Persisting or Worsening Impulse Control Disorders in Parkinson's Disease Following a Switch to Subcutaneous Foslevodopa-Foscarbidopa

Bradley M, Donlon E, Gallagher A, Ruggieri F, Inocentes J, Rua AD, O'Keeffe C, Lynch T, Fearon C, Walsh RA.

Mov Disord Clin Pract. 2026 May;13(5):1301-1305. doi: 10.1002/mdc3.70533. Epub 2026 Jan 14.

Speech Motor Deficits in Developmental Stuttering and Parkinson's Disease: From Cellular and Circuit to Network-Level Disruptions

Turk AZ, Millwater M, Sheikh-Bahaei S, Mollaei F, Riessland M, SheikhBahaei S.

Eur J Neurosci. 2026 Feb;63(3):e70393. doi: 10.1111/ejn.70393.

Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia

Zerbinati L, Cristilli G, Valier B, Braccia F, Okai D, Toffanin T, Verrienti M, Giampietro A, Grassi L, Zatelli MC, Ambrosio MR.

Pituitary. 2026 May 18;29(3):87. doi: 10.1007/s11102-026-01693-7.

Multimodal brain network topology and enhanced computer-aided diagnosis in Parkinson's Disease: a systematic review and meta-analysis

Zuo C, Liu W, Lan H, Chen L, Li N, Yan Y, Li L, Luo C, Kemp GJ, Lui S, Suo X, Gong Q.

NPJ Digit Med. 2026 Jan 7;9(1):121. doi: 10.1038/s41746-025-02301-x.

The Multifaceted Role of Irisin in Neurological Disorders: A Systematic Review Integrating Preclinical Evidence with Clinical Observations

Alzoughool F, Alanagreh L, Aljawarneh Y, Zraigat H, Alzghool M.

Neurol Int. 2026 Jan 9;18(1):15. doi: 10.3390/neurolint18010015.

The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwide

Flores-Ocampo V, Zirra A, Tay YW, van Midden V, Mata IF, Noyce AJ, Periñan MT; Global Parkinson's Genetics Program (GP2).

J Parkinsons Dis. 2026 May 20:1877718X261452868. doi: 10.1177/1877718X261452868. Online ahead of print.

A Comparative Analysis of iPSC, MSC, and 293T-Derived Exosomes for Parkinson's Disease Therapy

Chen KF, Lin SL, Kuo CH, Shyu WC, Jeng LB, Liu SP.

Int J Mol Sci. 2026 May 9;27(10):4212. doi: 10.3390/ijms27104212.

Is SORL1 a common genetic target across neurodegenerative diseases?: A multi-ancestry biobank scale assessment

Khani M, Yeboah SN, Cerquera-Cleves C, Kedmi A, Bustos BI, Grant SM, Akerman SC, Akçimen F, Lee PS, Reyes-Pérez P, Lange LM, Leonard H, Koretsky MJ, Makarious MB, Schneider Z, Jonson C, Chen PS, Tay YW, Rothstein JD, Lin CH, Lim SY, Klein C, Merchant K, Mencacci NE, Krainc D, Cookson MR; Global Parkinson’s Genetics Program (GP2); Singleton A, Bandres-Ciga S.

medRxiv [Preprint]. 2026 Feb 2:2026.01.24.26344530. doi: 10.64898/2026.01.24.26344530.

Bilirubin in Parkinson's disease: pathogenic mechanisms and therapeutic potentials

Wan Y, Xie C, Wang Q, Wang X.

Front Neurosci. 2026 Apr 28;20:1806875. doi: 10.3389/fnins.2026.1806875. eCollection 2026.

Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score

Okubadejo NU, Schaeffer E, Noyce AJ, Heinzel S, Burn DJ, Fung VS, Postuma RB, Berg D.

Mov Disord. 2026 May;41(5):1085-1090. doi: 10.1002/mds.70231. Epub 2026 Feb 17.

Resolution of Levodopa/Dopa-Decarboxylase Inhibitor-Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

Hintner R, Eberhardt F, Kofler M, Eigentler A, Djamshidian A, Krismer F, Hittmair A, Zoller H, Ellinger V, Heim B, Seppi K.

Mov Disord Clin Pract. 2026 Feb 11. doi: 10.1002/mdc3.70554. Online ahead of print.

Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins

Puerta R, García-González P, de Rojas I, Capdevila-Bayo M, Olivé C, Muñoz-Morales Á, Bayón-Buján P, Valenzuela A, Yang C, Timsina J, Liu M, Chakkarai S, Sotolongo-Grau O, Calm B, Miguel A, Solivar A, Montrreal L, Martínez M, Khan A, Zhao F, Tantinyà N, Rosende-Roca M, Alegret M, Moreno-Grau S, Fernández MV, Marquié M, Valero S, Cavazos JE, Sanz P, Montalban X, Tàrraga L, Smets B, Boada M, Seshadri S, Sargurupremraj M, Cruchaga C, Cano A, Cabrera-Socorro A, Ruiz A.

medRxiv [Preprint]. 2026 Feb 22:2026.02.12.26345733. doi: 10.64898/2026.02.12.26345733.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias